Infectious Disease Diagnostics Testing Market Size, Share Global Analysis Report, 2023 – 2030

Industry Insights

[195+ Pages Report] According to the report published by Facts Factors, the global infectious disease diagnostics testing market size was worth around USD 34.95 billion in 2022 and is predicted to grow to around USD 48.75 billion by 2030 with a compound annual growth rate (CAGR) of roughly 4.87% between 2023 and 2030. The report analyzes the global infectious disease diagnostics testing market drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the infectious disease diagnostics testing market.

This specialized and expertise oriented industry research report scrutinizes the technical and commercial business outlook of the Infectious disease diagnostics industry. The report analyzes and declares the historical and current trends analysis of the Infectious disease diagnostics industry and subsequently recommends the projected trends anticipated to be observed in the infectious disease diagnostics market during the upcoming years.

The Infectious disease diagnostics market report analyzes and notifies the industry statistics at the global as well as regional and country levels in order to acquire a thorough perspective of the entire infectious disease diagnostics market. The historical and past insights are provided for FY 2020 to FY 2022 whereas projected trends are delivered for FY 2023 to FY 2030. The quantitative and numerical data is represented in terms of value (USD Billion) from FY 2020-2023.

Key Insights from Primary Research

• As per our analysis, the infectious disease diagnostics market is set to grow annually at a rate of around 4.87%
• It was valued through primary research that the infectious disease diagnostics market was valued at around USD 34.95 Billion in 2022
• North America is currently holding the largest share among all the regions and expected to rise in the upcoming period
• The market may rise as there is a consistent rise in the number of patients suffering from numerous infectious diseases

Key Recommendations from Analysts

• As per our analysis, it was anticipated that during the forecast period the market value may rise owing to high growth in under-developed as well as developing countries across the world
• The market value for the year 2022 was estimated at USD 15.8 Billion
• Asia-Pacific region is likely to grow fastest in the estimated period
• As per our analysts, growth in funding of research for infectious diseases is likely to support the overall market growth

The quantitative data is further underlined and reinforced by comprehensive qualitative data which comprises various across-the-board market dynamics. The rationales which directly or indirectly impact the Infectious disease diagnostics industry are exemplified through parameters such as growth drivers, restraints, challenges, and opportunities among other impacting factors.

Throughout our research report, we have encompassed all the proven models and tools of industry analysis and extensively illustrated all the key business strategies and business models adopted in the Infectious disease diagnostics industry. The report provides an all-inclusive and detailed competitive landscape prevalent in the Infectious disease diagnostics market.

The report utilizes established industry analysis tools and models such as Porter’s Five Forces framework to analyze and recognize critical business strategies adopted by various stakeholders involved in the entire value chain of the Infectious disease diagnostics industry. The Infectious disease diagnostics market report additionally employs SWOT analysis and PESTLE analysis models for further in-depth analysis.

The report study further includes an in-depth analysis of industry players' market shares and provides an overview of leading players' market position in the Infectious disease diagnostics sector. Key strategic developments in the Infectious Disease Diagnostics market competitive landscape such as acquisitions & mergers, inaugurations of different products and services, partnerships & joint ventures, MoU agreements, VC & funding activities, R&D activities, and geographic expansion among other noteworthy activities by key players of the Infectious disease diagnostics market are appropriately highlighted in the report.

Infectious diseases such as respiratory diseases, bacterial infections, HIV, and HPV are gradually growing throughout the world. For example, the WHO Global Health Observatory (GHO) study estimated that 36-39 million people worldwide suffered from HIV in 2013. Infectious diseases are endangering public health and contributing significantly to the growing costs of health care. Infectious disease diagnostic tests help identify existing pathogens and new pathogens, assess prognosis, track the therapy response, and evaluate adequate treatment. Advances in instrument-based analyzes and microfluidics have allowed infectious disease testing to proliferate in developing countries across institutional sites such as reference laboratories through mobile clinics (MOLs). More support for infectious disease research from NGOs, international regulatory agencies, and non-profit health organizations continues to build up a new generation of innovative testing technologies designed to meet minimum-resource needs.

The global infectious disease diagnostics market is segmented on the basis of the type of testing and region. On the basis of the type of testing, the market is divided into the molecular diagnostic tests, respiratory, HIV, HAIs, sexual health, tropical diseases, liver, and others. The global infectious disease diagnostics market is analyzed into the following regions namely, Asia Pacific, Latin America, North America, Europe, and the Middle East and Africa.

The infectious disease diagnostics market research report delivers an acute valuation and taxonomy of the Infectious disease diagnostics industry by practically splitting the market on the basis of different types, applications, and regions. Through the analysis of the historical and projected trends, all the segments and sub-segments were evaluated through the bottom-up approach, and different market sizes have been projected for FY 2023 to FY 2030.

Report Scope

The regional segmentation of the Infectious disease diagnostics industry includes the complete classification of all the major continents including North America, Latin America, Europe, Asia Pacific, and the Middle East & Africa. Further, country-wise data for the infectious disease diagnostics industry is provided for the leading economies of the world.

Some of the leading players in the global market include

• Abbott Diagnostic
•  bioMérieux
•  Alere
•  Roche Diagnostic
•  Diasorin
•  Becton
•  Dickinson and Company (BD)
•  Beckman Coulter
•  Bio-Rad Laboratories
•  Corgenix
•  Epitope Diagnostic

The taxonomy of the Infectious disease diagnostics industry by its scope and segmentation is as follows:

By Type of Testing Segmentation Analysis

• Molecular Diagnostic Test
• Respiratory
• HIV
• HAIs
• Sexual Health
• Tropical Diseases
• Liver
• Others

By Regional Segmentation Analysis

• North America
  • The U.S.
  • Canada
• Europe
  • Germany
  • The UK
  • France
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa